Literature DB >> 34545351

BI-RADS 3 on Screening Breast Ultrasound: What Is It and What Is the Appropriate Management?

Wendie A Berg1.   

Abstract

US is widely used in breast imaging for diagnostic purposes and is also used increasingly for supplemental screening in women with dense breasts. US frequently depicts masses that are occult on mammography, even after tomosynthesis, and the vast majority of such masses are benign. Many masses seen only on screening US are easily recognized as benign simple cysts. Probably benign, BI-RADS 3, or low suspicion, BI-RADS 4A masses are also common and often prompt short-interval follow-up or biopsy, respectively, yet the vast majority of these are benign. This review details appropriate characterization, classification, and new approaches to the management of probably benign masses seen on screening US that can reduce false positives and, thereby, reduce costs and patient anxiety. © Society of Breast Imaging 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  BI-RADS 3; breast cancer; breast ultrasound; probably benign; screening

Year:  2021        PMID: 34545351      PMCID: PMC8445238          DOI: 10.1093/jbi/wbab060

Source DB:  PubMed          Journal:  J Breast Imaging        ISSN: 2631-6110


  66 in total

1.  Combination of different types of elastography in downgrading ultrasound Breast Imaging-Reporting and Data System category 4a breast lesions.

Authors:  Xueyi Zheng; Yini Huang; Yun Wang; Yubo Liu; Fei Li; Jing Han; Jianwei Wang; Longhui Cao; Jianhua Zhou
Journal:  Breast Cancer Res Treat       Date:  2018-12-04       Impact factor: 4.872

2.  Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.

Authors:  Regina J Hooley; Kathryn L Greenberg; Rebecca M Stackhouse; Jaime L Geisel; Reni S Butler; Liane E Philpotts
Journal:  Radiology       Date:  2012-06-21       Impact factor: 11.105

3.  Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.

Authors:  Eun Young Chae; Joo Hee Cha; Hee Jung Shin; Woo Jung Choi; Hak Hee Kim
Journal:  AJR Am J Roentgenol       Date:  2016-03       Impact factor: 3.959

4.  Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.

Authors:  Eda Elverici; Ayşe Nurdan Barça; Hafize Aktaş; Arzu Özsoy; Betül Zengin; Mehtap Çavuşoğlu; Levent Araz
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

5.  Added value of shear-wave elastography for evaluation of breast masses detected with screening US imaging.

Authors:  Su Hyun Lee; Jung Min Chang; Won Hwa Kim; Min Sun Bae; Mirinae Seo; Hye Ryoung Koo; A Jung Chu; Hye Mi Gweon; Nariya Cho; Woo Kyung Moon
Journal:  Radiology       Date:  2014-06-19       Impact factor: 11.105

6.  Reducing Unnecessary Biopsy and Follow-up of Benign Cystic Breast Lesions.

Authors:  Wendie A Berg
Journal:  Radiology       Date:  2020-02-18       Impact factor: 11.105

7.  Real world performance of screening breast ultrasound following enactment of Connecticut Bill 458.

Authors:  Tchaiko Parris; Dorothy Wakefield; Heather Frimmer
Journal:  Breast J       Date:  2012-12-13       Impact factor: 2.431

8.  Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.

Authors:  Richard G Barr; Zheng Zhang; Jean B Cormack; Ellen B Mendelson; Wendie A Berg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

9.  Complicated breast cysts on sonography: is aspiration necessary to exclude malignancy?

Authors:  Caroline P Daly; Janet E Bailey; Katherine A Klein; Mark A Helvie
Journal:  Acad Radiol       Date:  2008-05       Impact factor: 3.173

10.  Revisiting the mammographic follow-up of BI-RADS category 3 lesions.

Authors:  Ximena Varas; José H Leborgne; Francisco Leborgne; Julieta Mezzera; Sylvia Jaumandreu; Felix Leborgne
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

View more
  1 in total

1.  Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.

Authors:  Tetsu Hayashida; Erina Odani; Masayuki Kikuchi; Aiko Nagayama; Tomoko Seki; Maiko Takahashi; Noriyuki Futatsugi; Akiko Matsumoto; Takeshi Murata; Rurina Watanuki; Takamichi Yokoe; Ayako Nakashoji; Hinako Maeda; Tatsuya Onishi; Sota Asaga; Takashi Hojo; Hiromitsu Jinno; Keiichi Sotome; Akira Matsui; Akihiko Suto; Shigeru Imoto; Yuko Kitagawa
Journal:  Cancer Sci       Date:  2022-08-03       Impact factor: 6.518

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.